Using bioorthogonal click chemistry, reactive oxygen species (ROS)-responsive luteolin-loaded micelles were tethered to the surface of MSCs. [Journal of Controlled Release]
Researchers linked the domain structure in tensin-3 (TNS3) to RhoA activity via actin dynamics and implicated an important role for TNS3 in regulating osteogenesis and adipogenesis from bone marrow-derived stromal cells. [Cellular and Molecular Life Sciences]
The potential of the MSCBMP-9-secretome to induce osteoblast differentiation and bone formation shed lights on novel cell-free-based therapies to promote bone regeneration of challenging defects. [Journal of Cellular Physiology]
To define the full spectrum of TWIST1 activity in MSCs, the authors employed integrated omics-based profiling to identify a high confidence set of TWIST1 targets. [Stem Cells]
Scientists showed that lncRNA RMRP was upregulated by TiO2 nanotubes to promote osteogenic differentiation through DLEU2/EZH2-mediated epigenetic modifications. [Biomedical Materials]
A pentavalent vanadium-doped mesoporous bioactive glass was prepared, and its effects on osteogenic differentiation of rat bone marrow MSCs and potential signaling pathways were investigated. [ACS Applied Bio Materials]
Mouse bone marrow-derived MSCs were used to treat an acute-on-chronic liver failure mouse model or cocultured with RAW264.7/J774A.1 macrophages that were stimulated with LPS. [Stem Cells]
Total flavonoids of Rhizoma drynariae improved tendon-bone healing in anterior cruciate ligament reconstruction mouse models and facilitated the osteogenic differentiation of bone MSCs through the ERR1/2-Gga1-TGF-β/MAPK pathway. [Environmental Toxicology]
Scientists review MSCs and their therapeutic potential in various diseases, including acute lung injury. They also consider the potential of MSC-based cell-free therapy for future clinical treatment. [Journal of Cellular Biochemistry]
Professor Kiss-Tóth and Professor Wilkinson are now jointly leading a preclinical program to test Stem CellX technologies for the development of a similar stem cell treatment in human patients. [University of Sheffield]